Calyxt Announces Collaboration with NRGene® to Advance its Product Pipeline

NRGene’s Genomics Platform to Accelerate Calyxt’s Trait Discovery in Hemp Roseville, MN – November 11, 2020 – Calyxt, Inc. (NASDAQ:...
Read More

Calyxt Reports Third Quarter 2020 Financial Results

Execution of Commercial Agreement with S&W Seed Company on IQ™ Alfalfa Product, Marking Calyxt’s First Trait License Agreement Significant Progress...
Read More

Calyxt Announces Commercial Agreement with S&W Seed Company to Deliver Improved Quality Alfalfa

Agreement has the Potential to Generate More Than $10 Million of License Revenue from U.S. Sales Roseville, MN – October...
Read More

Calyxt to Host Virtual Analyst Day on Tuesday, November 17, 2020 at 4:00 p.m. Eastern Time

Roseville, MN – October 27, 2020 – Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will host a Virtual Analyst Day on...
Read More

Calyxt Announces Closing of Registered Direct Offering of Common Stock

Roseville, MN – Oct. 20, 2020  – Calyxt, Inc. (NASDAQ: CLXT) (the “Company”), a plant-based technology company, today announced the...
Read More
Next »